The grades of three Health Care Provider stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.
Molina Healthcare (NYSE:MOH) is bumping up its rating from a C (“hold”) to a B (“buy”) this week. Molina Healthcare is a multi-state managed care organization that participates in government-sponsored health care programs such as Medicaid and the Children’s Health Insurance Program. In Portfolio Grader’s specific subcategories of Earnings Revisions and Sales Growth, MOH also gets A’s. The stock price has risen 8% over the past month, better than the 2.8% increase the S&P 500 has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of MOH stock.
Magellan Health Services (NASDAQ:MGLN) shows solid improvement this week. The company’s rating rises from a C to a B. Magellan Health Services coordinates and manages the delivery of behavioral healthcare treatment services. For more information, get Portfolio Grader’s complete analysis of MGLN stock.
This week, China Cord Blood’s (NYSE:CO) ratings are up from a C last week to a B. China Cord Blood engages in the provision of umbilical cord blood storage and ancillary services in its cord blood banks. The stock has a trailing PE Ratio of 9.90. For more information, get Portfolio Grader’s complete analysis of CO stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.